chr10-87952137-A-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The NM_000314.8(PTEN):c.512A>G(p.Gln171Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q171H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTEN | NM_000314.8 | c.512A>G | p.Gln171Arg | missense_variant | Exon 6 of 9 | ENST00000371953.8 | NP_000305.3 | |
| PTEN | NM_001304717.5 | c.1031A>G | p.Gln344Arg | missense_variant | Exon 7 of 10 | NP_001291646.4 | ||
| PTEN | NM_001304718.2 | c.-80A>G | 5_prime_UTR_variant | Exon 6 of 9 | NP_001291647.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTEN | ENST00000371953.8 | c.512A>G | p.Gln171Arg | missense_variant | Exon 6 of 9 | 1 | NM_000314.8 | ENSP00000361021.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
PTEN hamartoma tumor syndrome Pathogenic:1Uncertain:1
NM_000314.8(PTEN):c.512A>G (p.Gln171Arg) is currently classified as likely pathogenic for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (ACMG Classification Rules Specified for PTEN Variant Curation version 3.1.0). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). PM6_met De novo (without paternity & maternity confirmed) SCV001757442.1: Gdx #1: de novo via targeted testing in female infant with macrocephaly, dev delays. PM6 (peds score of 4) PS3_moderate Mighell et al. 2018 PMID: 29706350: Lipid phosphatase activity score, -3.85 (TRUE and functionally deleterious). No additional weight was added but in Matreyek et al. 2018 (PMID: 29785012) the abundance class was low PP2_met Missense in gene with low rate of benign missense variants and path. missenses common Missense constraint PP3_met Multiple lines of computational evidence support a deleterious effect on the gene /gene product REVEL score of 0.975 PM2_supporting Absent in population databases PM2_supporting Absent in gnomAD v2 and v4 PS4_supporting Prevalence in affected statistically increased over controls PS4_supporting PMID:39129943: Child at CHOP (ID CHOP-21): patient had clinical features that were convincing enough to treat as PHTS regardless of variant – macrocephaly, vascular malformation, developmental delay / autism spectrum disorder. Peds score of 6, so PS4_P applies for one proband point.
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects PTEN function (PMID: 34943931). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 171 of the PTEN protein (p.Gln171Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with PTEN-related conditions (PMID: 22970944, 35227301). ClinVar contains an entry for this variant (Variation ID: 189412). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PTEN protein function.
Prostate cancer;C1854416:Macrocephaly-autism syndrome;C2751642:Glioma susceptibility 2;C3551915:Familial meningioma;CN072330:Cowden syndrome 1 Pathogenic:1
Cowden syndrome 1 Pathogenic:1
This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 38546160, 22970944, 35227301]. Functional studies indicate this variant impacts protein function [PMID: 34943931, 32350270]. This variant is expected to disrupt protein structure [Myriad internal data].
not provided Pathogenic:1
Classification criteria: PM2_supporting, PP3, PP2, PS3_moderate, PS2
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Q171R variant (also known as c.512A>G), located in coding exon 6 of the PTEN gene, results from an A to G substitution at nucleotide position 512. The glutamine at codon 171 is replaced by arginine, an amino acid with highly similar properties. This alteration has been reported in a patient meeting clinical criteria for Cowden syndrome (Pal A et al. N Engl J Med, 2012 Sep;367:1002-11). In a massively parallel functional assay using a humanized yeast model, lipid phosphatase activity for this variant was functionally deficient (Mighell TL et al. Am J Hum Genet, 2018 May;102:943-955). In addition, this variant demonstrated low intracellular protein abundance in a massively parallel functional assay (Matreyek KA et al. Nat Genet, 2018 Jun;50:874-882). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.
not specified Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at